ViiV Healthcare wins Japanese approval for Dovato to treat HIV-1

Drug Discovery |  News | 0 Comment | 20 Jan, 2020

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced that it has obtained approval of Dovato (dolutegra...Read more

InterVenn Biosciences advances glycoproteomics for complex disease therapies

Drug Discovery |  News | 0 Comment | 17 Jan, 2020

US based InterVenn Biosciences has announced multiple achievements in its development of AI-enabled glycoproteomics, as it looks to solving difficult challenges in various disease areas of ...Read more

Charles River inks scientific collaboration with Takeda

Drug Discovery |  News | 0 Comment | 16 Jan, 2020

US based company Charles River has announced a multi-year drug discovery collaboration with Japanese firm Takeda Pharmaceutical Company Limited. Together, Charles River and Takeda will laun...Read more

Hitachi starts commercial manufacturing of Zynteglo

Drug Discovery |  News | 0 Comment | 15 Jan, 2020

apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manufacturing of cell and gene therapeutics, starts the commercial manufa...Read more

FDA approves sNDA for Astellas’s antifungal drug

Drug Discovery |  News | 0 Comment | 13 Jan, 2020

Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for MYCAMINE® (micafungin ...Read more

China approves AstraZeneca’s Lokelma to treat hyperkalaemia

Drug Discovery |  News | 0 Comment | 07 Jan, 2020

AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of adult patients with hyperkalaemia (elevated levels of potassium in the...Read more

China grants priority review to Luye Pharma's schizophrenia drug

Drug Discovery |  News | 0 Comment | 02 Jan, 2020

Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for Injection (LY03004), an innovative formulation independently developed ...Read more

AstraZeneca’s triple-combination therapy gets approval in China for COPD

Drug Discovery |  News | 0 Comment | 01 Jan, 2020

AstraZeneca has announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This ...Read more

Luye Pharma seeks USFDA approval for antidepressant drug

Drug Discovery |  News | 0 Comment | 30 Dec, 2019

China based Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for LY03005, a new chemical drug for the treatment of m...Read more

USFDA approves Daiichi Sankyo and AstraZeneca’s breast cancer drug

Drug Discovery |  News | 0 Comment | 26 Dec, 2019

Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU® (fam-trastuzumab deruxtecan-nxki), a HER2 directed antibody drug con...Read more

Allergan gets FDA nod for acute migraine treatment

Drug Discovery |  News | 0 Comment | 24 Dec, 2019

The U.S. Food and Drug Administration has approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturba...Read more

Eisai gets USFDA nod for insomnia drug

Drug Discovery |  News | 0 Comment | 24 Dec, 2019

Eisai has announced that the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and 10 mg for the treatment of adult patients with insomnia, characteriz...Read more

BeiGene cancer drug misses mark in Phase III study

Drug Discovery |  News | 0 Comment | 20 Dec, 2019

China based BeiGene,  a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment...Read more

Takeda, Turnstone Biologics to develop novel viral immunotherapies

Drug Discovery |  News | 0 Comment | 20 Dec, 2019

US based Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies, has  announced a strategic collaboration with Japan based Tak...Read more

European Commission approves Roche’s breast cancer drug

Drug Discovery |  News | 0 Comment | 19 Dec, 2019

Roche has announced that the European Commission has approved Kadcyla® (trastuzumab emtansine) for the adjuvant (after surgery) treatment of adult patients with HER2-positive early brea...Read more

Pfizer, Astellas' Xtandi Gets FDA nod

Drug Discovery |  News | 0 Comment | 17 Dec, 2019

Pfizer and Japan based Astellas Pharma have announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for XTANDI® (enzaluta...Read more

AstraZeneca, Daiichi Sankyo’s trastuzumab shows promise in Phase II Trial

Drug Discovery |  News | 0 Comment | 16 Dec, 2019

AstraZeneca and Daiichi Sankyo Company presented positive detailed data from the global pivotal Phase II single-arm DESTINY-Breast01 trial of trastuzumab deruxtecan (DS-8201), a HER2-target...Read more

Brii Biosciences expands focus to neurosciences

Drug Discovery |  News | 0 Comment | 04 Dec, 2019

Brii Biosciences, a clinical-stage company committed to serving patients’ needs and improving public health in China and around the world, has announced two leadership appointments th...Read more